Suppliers / Anthem Biosciences

Anthem Biosciences

India Updated 9 July 2026

Anthem Biosciences is a finished-dose manufacturer based in India. It holds 2 active US drug master files. Its filings concentrate with CDSCO (India) and MINSA (CR). Its GMP standing is certified by CDSCO (India) and US FDA. Its most recent recorded inspection, by US FDA, closed on 24 January 2025 as NAI. Customs aggregates show $151.5M of exports covering 1,223 molecules to 47 destinations in 2025.

2
active US DMFs
0
valid CEPs
7
registered plants 3 with an FDA FEI number
6
filings across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
3 of 3 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 24 January 2025 NAI US FDA
  • 29 March 2024 NAI US FDA
  • 14 August 2019 NAI US FDA
  • 10 October 2013 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Bengaluru, India 3017542362
Bengaluru, India 3008300442
Bengaluru South District, India 3013884349
ramanagara, India Not on file
bengaluru 560 099, India Not on file
Bengaluru, India Not on file

1 further sites are on record.

What they file, and where

Molecule Regulators Docs
Calcium US FDA 2

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
CDSCO (India) 3 4
MINSA (CR) 3 None
US FDA None 2

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $43.3M 25
2025 Not reported $151.5M 47
2024 Not reported $160.4M 43
2023 Not reported $78.6M 50

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Anthem Biosciences

Does Anthem Biosciences hold a US DMF or a CEP?
Anthem Biosciences holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Anthem Biosciences FDA-registered?
3 sites operated by Anthem Biosciences carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Anthem Biosciences's last inspection go?
The most recent inspection on record closed on 24 January 2025 as NAI (No Action Indicated: nothing objectionable was found). 4 inspections are on file.
Where does Anthem Biosciences manufacture?
7 registered sites are on record, in India (Bengaluru, Bengaluru South District and Ramanagara among others). Every site is listed on this page with the register it came from.
What does Anthem Biosciences make?
1 molecule is on record against Anthem Biosciences, including Calcium. Each links through to that molecule's full manufacturer list.
Which regulators recognise Anthem Biosciences's GMP?
Current GMP certificates are on record from CDSCO (India) and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Anthem Biosciences comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 24 January 2025.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts